Experience

Edity Therapeutics

• Israel
• Biotechnology Research
• 1 - 100 Employee

• VP R&D

  • Jun 2020 - Present

  Reẖovot, Central, Israel



OncologyFirst

• Partner

  • Oct 2019 - Apr 2020

  Israel OncologyFirst is a new VC fund being established these days for materializing the opportunity of transforming Israeli academic oncology breakthrough discoveries into commercial assets, through a unique hands-on collaborative investment model of professionals, pharmaceutical experts, capital, and industry partners.



Compugen

• Israel
• Biotechnology Research
• 1 - 100 Employee

• Director, Academic collaborations & Target Validarion

  • Jul 2017 - Sep 2019

  Israel • Chairman of “Governance Committee”, responsible for oversight of company's early stage pipeline • Led processes across the organization to identify high quality targets in Company’s focus areas, including COM701, an anti-PVRIG antibody, currently in Phase I trials • Project leader for multiple programs in Company’s pre-clinical pipeline • Core team member in cancer immunotherapy research & license collaboration agreement with Bayer Healthcare • Build external relationships and… Show more • Chairman of “Governance Committee”, responsible for oversight of company's early stage pipeline • Led processes across the organization to identify high quality targets in Company’s focus areas, including COM701, an anti-PVRIG antibody, currently in Phase I trials • Project leader for multiple programs in Company’s pre-clinical pipeline • Core team member in cancer immunotherapy research & license collaboration agreement with Bayer Healthcare • Build external relationships and collaborations to supplement the group’s internal capabilities with KOLs in the Immuno-Oncology space

• Principal Scientist

  • Sep 2012 - Jul 2017

  Israel Initiation and management of scientific collaborations with academia. Scientific leadership of therapeutic programs.

• Senior Scientist

  • May 2006 - Sep 2012

  Israel